Abstract
Hemodialysis (HD) vascular access dysfunction is currently a huge clinical problem for which there are no effective therapies. There are, however, a number of promising technologies that are currently at the experimental or clinical trial stage. We believe that the application of these novel technologies in combination with better clinical protocols for vascular access care could significantly reduce the current problems associated with HD vascular access.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Review
MeSH terms
-
Arteriovenous Shunt, Surgical* / adverse effects
-
Blood Vessel Prosthesis Implantation* / adverse effects
-
Catheters, Indwelling* / adverse effects
-
Clinical Protocols
-
Graft Occlusion, Vascular / etiology
-
Graft Occlusion, Vascular / prevention & control*
-
Humans
-
Kidney Failure, Chronic / therapy*
-
Organizational Objectives
-
Patient Care Management / organization & administration*
-
Patient Care Team / organization & administration
-
Renal Dialysis*
-
Treatment Failure
-
Treatment Outcome
-
Vascular Patency